First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study. (Q51452174)
Jump to navigation
Jump to search
scientific article published on 11 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study. |
scientific article published on 11 January 2012 |
Statements
1 reference
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study. (English)
1 reference
1 reference
1 reference
1 reference
Axel Le Cesne
1 reference
George D Demetri
1 reference
Sant P Chawla
1 reference
Thomas Brodowicz
1 reference
Dominic P Smethurst
1 reference
Sarah Bray
1 reference
Yong-jiang Hei
1 reference
11 January 2012
1 reference
48
1 reference
547-563
1 reference
4
1 reference
Identifiers
1 reference